You are viewing an incomplete version of our website. Please click to reload the website as full version.

Phosphothreonine antibody

Details for Product No. ABIN361807, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

(83), (3), (1)
(66), (20)
Clonality (Clone)
Monoclonal ()
(10), (9), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
ELISA, Western Blotting (WB)
(80), (67), (54), (19), (17), (14), (11), (3), (1), (1), (1), (1)
Pubmed 4 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 μL
Shipping to United States ( )
Immunogen Phosphothreonine conjugated to KLH
Clone 18F9
Isotype IgG1 kappa
Specificity Reacts with phosphothreonine, and detects the presence of phosphothreonine in proteins of both un-stimulated and stimulated cell lysates. Does not cross-react with phosphoserine or phosphotyrosine.
Cross-Reactivity (Details) Does not cross-react with phosphoserine or phosphotyrosine.
Purification Ascites
Background Protein phosphorylation is an important posttranslational modification that serves many key functions to regulate a protein’s activity, localization, and protein-protein interactions. Phosphorylation is catalyzed by various specific protein kinases, which involves removing a phosphate group from ATP and covalently attaching it to to a recipient protein that acts as a substrate. Most kinases act on both serine and threonine, others act on tyrosine, and a number (dual specificity kinases) act on all three. Because phosphorylation can occur at multiple sites on any given protein, it can therefore change the function or localization of that protein at any time. Changing the function of these proteins has been linked to a number of diseases, including cancer, diabetes, heart disease, inflammation and neurological disorders.
Research Area Signaling, Metabolism, Amino Acids, Protein Modifications, Cell Signaling
Application Notes Recommended Dilution: 1:2000 to 1:10000
Restrictions For Research Use only
Format Liquid
Concentration 1 mg/mL
Storage -20 °C
Background publications Goto, Kiyono, Tomono et al.: "Complex formation of Plk1 and INCENP required for metaphase-anaphase transition." in: Nature cell biology, Vol. 8, Issue 2, pp. 180-7, 2006 (PubMed).

Downward: "The ins and outs of signalling." in: Nature, Vol. 411, Issue 6839, pp. 759-62, 2001 (PubMed).

Blume-Jensen, Hunter: "Oncogenic kinase signalling." in: Nature, Vol. 411, Issue 6835, pp. 355-65, 2001 (PubMed).

Pawson, Saxton: "Signaling networks--do all roads lead to the same genes?" in: Cell, Vol. 97, Issue 6, pp. 675-8, 1999 (PubMed).

Catalog No. ABIN361807

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)